Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ELAGOLIX SODIUM, with a corresponding US DMF Number 34907.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 09, 2021, and payment made on June 08, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II